1. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial. Issue 13 (October 2015) Authors: Burnett, Alan K; Russell, Nigel H; Hills, Robert K; Bowen, David; Kell, Jonathan; Knapper, Steve; Morgan, Yvonne G; Lok, Jennie; Grech, Angela; Jones, Gail; Khwaja, Asim; Friis, Lone; McMullin, Mary Frances; Hunter, Ann; Clark, Richard E; Grimwade, David Journal: Lancet oncology Issue: Volume 16:Issue 13(2015) Page Start: 1295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗